Ibuprofen B. Braun (Ibuprofen)

Ibuprofen works by reversibly inhibiting the cyclooxygenase enzymes COX‑1 and COX‑2, which reduces the production of prostaglandins—key mediators of pain, fever, and inflammatory processes.

The appropriate dose is determined by the prescribing clinician based on the patient’s condition, weight, renal function, and other clinical factors. Dosing regimens are individualized and should follow the prescriber’s instructions.

Safety in pregnancy has not been established; it should be avoided, especially in the third trimester, unless the potential benefit justifies the risk. Caution is also advised during breastfeeding, and the prescriber should evaluate the risk‑benefit balance.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with alternatives such as IV ketorolac, ibuprofen offers a similar analgesic and antipyretic profile but may have a slightly lower risk of renal adverse effects at equivalent doses. Choice between agents depends on individual patient factors, safety considerations, and institutional protocols.

Store the product at ambient temperature below 25 °C. Keep it in the original container, protect from moisture and direct light, and ensure the vial remains sealed until use to maintain sterility.

Ibuprofen B. Braun is administered intravenously by a qualified healthcare professional. The sterile solution is infused over a short period, typically via a peripheral or central IV line, according to the prescriber’s dosing instructions.

Serious risks include gastrointestinal bleeding or ulceration, severe renal impairment, anaphylactic reactions, Stevens‑Johnson syndrome, and cardiovascular thrombotic events such as myocardial infarction. Patients should be monitored for signs of these conditions during therapy.

Contraindications include patients with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcer or bleeding, severe renal or hepatic impairment, uncontrolled hypertension, and women in the third trimester of pregnancy.